A Multicenter, Single-Arm Study of the Effects of Atrasentan on Spermatogenesis and Testicular Function
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 01 Jun 2018
At a glance
- Drugs Atrasentan (Primary)
- Indications Diabetic nephropathies
- Focus Pharmacodynamics
- Sponsors AbbVie
- 25 May 2018 Planned End Date changed from 30 May 2019 to 18 Apr 2019.
- 13 Feb 2018 Planned primary completion date changed from 12 Dec 2017 to 19 Apr 2018.
- 01 Feb 2018 This trial has been completed in Spain.